Cenedella R J, Chandrasekher G
Department of Biochemistry, Kirksville College of Osteopathic Medicine, MO 65301.
Curr Eye Res. 1993 Nov;12(11):1025-38. doi: 10.3109/02713689309029230.
This study examines the high capacity binding of intact and carboxyl-terminal-truncated alpha A(alpha A) crystallin to two types of lens membrane preparations; membrane stripped of extrinsic protein and some lipid by extraction with urea and alkali and unextracted membrane isolated by centrifugation of total water insoluble protein on a sucrose gradient (native membrane). High capacity binding of alpha A crystallin to the urea-treated membrane was seen once the alpha A substrate concentration reached about 1 mg/ml of media. The membrane bound up to one mg of alpha A per mg of intrinsic protein (MP26) at a concentration of 5 mg alpha A/ml media, binding 5 to 10 times greater than that seen by others at saturation of the high affinity but low capacity binding sites. No apparent differences were seen between high capacity binding of carboxyl terminal-truncated alpha A (by trypsin) and intact alpha A, although each crystalline could antagonize binding of the other. However, once membrane bound, neither crystallin appeared to grossly displace the other. Using the carboxyl terminal-truncated alpha crystallin as a model substrate, native membrane was seen to have a higher capacity to bind the truncated alpha crystallin than urea-extracted membrane and binding was better correlated with the preexisting alpha A content of the native membrane than its MP26 content. An artificial native membrane was prepared by prebinding the truncated alpha A to urea-extracted membrane. This preparation bound more intact alpha A than urea-extracted membrane bearing no prebound crystallin. We conclude that lens native membrane possesses a high capacity to bind alpha crystallins and that this binding could be mediated through protein-protein interactions with alpha crystallin bound in situ to the membrane as extrinsic protein.
本研究检测了完整的和羧基末端截短的αA(αA)晶状体蛋白与两种晶状体膜制剂的高容量结合情况;一种是通过用尿素和碱提取而去除了外在蛋白和部分脂质的膜,另一种是通过在蔗糖梯度上对总水不溶性蛋白进行离心分离得到的未提取膜(天然膜)。当αA底物浓度达到约1mg/ml培养基时,可观察到αA晶状体蛋白与经尿素处理的膜的高容量结合。在5mgαA/ml培养基的浓度下,该膜每毫克内在蛋白(MP26)可结合高达1mg的αA,其结合量比其他人在高亲和力但低容量结合位点饱和时所观察到的结合量高5至10倍。羧基末端截短的αA(经胰蛋白酶处理)与完整的αA在高容量结合方面没有明显差异,尽管每种晶体蛋白都能拮抗另一种的结合。然而,一旦与膜结合,两种晶体蛋白似乎都不会明显取代对方。以羧基末端截短的α晶体蛋白作为模型底物,发现天然膜比尿素提取的膜具有更高的结合截短的α晶体蛋白的能力,并且结合与天然膜中预先存在的αA含量比其MP26含量的相关性更好。通过将截短的αA预先结合到尿素提取的膜上制备了一种人工天然膜。这种制剂比没有预先结合晶体蛋白的尿素提取的膜结合更多的完整αA。我们得出结论,晶状体天然膜具有高容量结合α晶体蛋白的能力,并且这种结合可能是通过与作为外在蛋白原位结合在膜上的α晶体蛋白的蛋白质-蛋白质相互作用介导的。